University Hospital Ghent
Ghent, 9000, Belgium
NCT Number: NCT00277732
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).
Looking for future studies?
Notify Me45 year–75 year
All sexes
Interventional
Not applicable
Ghent, 9000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline and after 6 months
Time frame: after 6 months
Time frame: after 6 months
Looking for future studies?
Notify MeUniversity Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02821117
Diabetes Mellitus, Endocrine System Diseases
Hanover, Germany
View Trial DetailsNCT05186389
Body Weight, Diabetes Mellitus
Paris, France
View Trial DetailsNCT02593032
Cardiovascular Diseases, Diabetes Mellitus
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06186245
Acid-Base Imbalance, Acidosis
Lubbock, Texas, United States
View Trial Details